Fish Oil Paradox

Fish oil has a near-halo status in nutrition culture: a simple, golden capsule that promises better memory, sharper thinking, and protection from cognitive decline. But a landmark longitudinal analysis using ADNI data and published in the Journal of Prevention of Alzheimer’s Disease forces a rethink, suggesting omega-3 supplement use in older adults may be linked to accelerated decline on major cognitive and functional scales. That tension between “common wisdom” and long-term human data is where we start, and we don’t let easy explanations off the hook. 

We walk through how the researchers compare supplement users and non-users over a five-year follow-up, why healthy user bias can mislead almost every supplement story, and how propensity score matching creates closer “statistical twins” across age, diagnosis, and APOE ε4 risk. We also tackle the most obvious defense, reverse causality, by looking at pre-supplement trajectories and the timing of decline. Then we quantify what “faster decline” means across MMSE, ADAS-Cog 13, and CDR-SB, translating abstract percentages into real-world loss of memory and independence. 

The biggest twist: the decline doesn’t seem to ride on the usual Alzheimer’s markers. Amyloid plaques, tau tangles, and gray matter loss don’t budge. Instead, FDG-PET points to reduced glucose metabolism, an “electrical brownout” where synapses lose energy even when the structure looks intact. From there we explore a plausible mechanism centered on DHA instability, lipid peroxidation, mitochondrial dysfunction, and a self-reinforcing oxidative cycle, plus why supplement quality and oxidation risk may separate “rancid reality” from purified trial products. We close with nuance, including the U-shaped dose-dependent paradox, and a bigger question about oxidizable fats in the modern diet. 
Subscribe for more deep dives, share this with a friend who takes fish oil, and leave a review with your take: are supplements helping your brain, or just sounding like they should?

This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice. 

Never miss an episode—subscribe on your favorite podcast app!

Transcript

Fish Oil’s Surprising New Risk

SPEAKER_01 0:00

If you open your medicine cabinet right now, there's uh a pretty high probability you've got a bottle of massive golden pills sitting on the shelf.

SPEAKER_00 0:08

Yeah, probably right next to the vitamin C.

SPEAKER_01 0:10

Exactly, fish oil. Omega-3 fatty acids. We take them because we've been told pretty much our whole lives that they are the ultimate brain food.

SPEAKER_00 0:18

Right, like a biological shield against cognitive decline.

SPEAKER_01 0:22

Aaron Powell Yeah, exactly. But a shocking 2026 longitudinal study suggests we might actually be swallowing a Trojan horse.

SPEAKER_00 0:30

Aaron Powell It's it's really wild data.

SPEAKER_01 0:32

Trevor Burrus It is. So today our mission is to investigate a scientific paradox that turns decades of nutritional dogma completely upside down.

SPEAKER_00 0:40

Aaron Powell And we're looking at a landmark paper from the Journal of Prevention of Alzheimer's disease.

SPEAKER_01 0:45

Aaron Powell Right, authored by Leo and colleagues, and they use data from the massive Alzheimer's disease neuroimaging initiative, or ADNI.

SPEAKER_00 0:53

Which is a fantastic data set.

SPEAKER_01 0:54

It really is. Okay, let's unpack this because the idea that the ultimate brain supplement might be accelerating the exact disease it's supposed to prevent, I mean, it goes against everything I thought I knew about neuronutrition.

SPEAKER_00 1:05

Well, the tension around this topic has actually been quietly building in the scientific community for years now.

SPEAKER_01 1:11

Really? How so?

SPEAKER_00 1:12

If we connect this to the bigger picture, the foundational logic for omega-3s makes perfect biological sense on paper, right?

SPEAKER_01 1:19

Sure, they reduce inflammation.

SPEAKER_00 1:21

Exactly. Animal models and observational data consistently highlighted their role in maintaining cell membrane fluidity and and resolving cerebral inflammation. Right. So based on that mechanism, researchers logically assumed that flooding an aging brain with EPA and DHA would protect neural circuitry.

SPEAKER_01 1:40

Makes sense. Give the brain more of what it's made of.

SPEAKER_00 1:42

Right. But the rigorous, randomized human clinical trials repeatedly hit a wall.

SPEAKER_01 1:47

Oh, wow.

SPEAKER_00 1:48

Yeah. Time after time, these highly controlled interventions produced frustratingly neutral results. They just showed no statistically significant cognitive benefit for older adults.

SPEAKER_01 1:57

Aaron Powell Okay, but a neutral result just means it didn't help. Right. Like maybe it's a waste of money, but it's harmless. But Lau and colleagues didn't just find a lack of benefit in the ADNI data.

SPEAKER_00 2:07

No, they didn't.

SPEAKER_01 2:08

They found active measurable

Neutral Trials Versus Harm Signal

SPEAKER_01 2:10

harm.

SPEAKER_00 2:10

Yes.

SPEAKER_01 2:11

So to understand how they isolated this effect, we need to look at the cohort. Who exactly were they tracking over these five years?

SPEAKER_00 2:18

Aaron Ross Powell So the researchers analyzed a cohort of 819 older adults from the ADNI database.

SPEAKER_01 2:24

Okay.

SPEAKER_00 2:24

The median age was right around 73 years old. And within this group, they identified 273 individuals who actively reported using omega-3 supplements.

SPEAKER_01 2:36

Aaron Powell And they compared them to the rest.

SPEAKER_00 2:37

Exactly. They compared them against 546 non-users, and they tracked both groups' cognitive and neurological trajectories over a median follow-up period of five years.

SPEAKER_01 2:47

Five years is, I mean, that's an eternity in clinical research.

SPEAKER_00 2:51

It really is a long time to track someone.

SPEAKER_01 2:52

But uh, any time we talk about supplement studies, a massive red flag goes up for me.

SPEAKER_00 2:56

The healthy user bias?

SPEAKER_01 2:58

Exactly. The healthy user bias. The people who habitually take vitamins and fish oil are usually the same people who, you know, meditate, eat organic leafy greens, and avoid processed sugars.

SPEAKER_00 3:07

Yeah, they jog on weekends.

SPEAKER_01 3:08

Yeah. We usually see a built-in protective effect just from their lifestyle. So how do we know the study isn't just capturing the noise of two fundamentally different demographic profiles?

SPEAKER_00 3:19

That's a great question. And the researchers recognize that exact bias. So they deployed a really rigorous statistical countermeasure called propensity score matching.

SPEAKER_01 3:30

Propensity score matching. Okay, what does that actually do?

SPEAKER_00 3:33

It means they didn't just casually compare the two groups, they mathematically forced an apples to apples comparison.

SPEAKER_01 3:40

Oh, interesting.

SPEAKER_00 3:40

Yeah. They matched the omega-3 users and non-users across a strict matrix of variables. So age, sex, their baseline clinical diagnosis. Okay. And crucially their APOE Epsilon 4 genetic status, which is a massive independent variable for Alzheimer's risk.

SPEAKER_01 3:56

So they basically created statistical twins.

SPEAKER_00 3:58

Precisely. They stripped away

Who Was Studied And For How Long

SPEAKER_00 4:00

the lifestyle noise, so the only major divergent variable was the omega-3 supplementation.

SPEAKER_01 4:04

And with the playing field leveled like that, the healthy user bias neutralized, the data revealed that the omega-3 users experienced accelerated cognitive decline compared to their matched counterparts.

SPEAKER_00 4:15

Which is just it's a stunning finding.

SPEAKER_01 4:17

I have to admit, my immediate reaction to this was pure skepticism.

SPEAKER_00 4:21

Oh, totally understandable.

SPEAKER_01 4:22

I just assumed this had to be a classic case of reverse causality. Like, wait, isn't it possible that people only started taking the supplements because they felt their memory slipping?

SPEAKER_00 4:31

Right. The classic chicken or the egg scenario.

SPEAKER_01 4:33

Yeah. People don't just wake up at 73 and randomly decide to start taking heavy doses of fish oil. They usually do it because they misplace their keys twice in one week, you know?

SPEAKER_00 4:42

Yeah, they feel something slipping.

SPEAKER_01 4:44

Exactly. So the decline would have already been in motion before they ever opened the bottle.

SPEAKER_00 4:48

Aaron Powell Well, what's fascinating here is that the ADI data set actually allowed the researchers to test that exact hypothesis.

SPEAKER_01 4:57

Oh, really? Because of the timeline.

SPEAKER_00 5:00

Exactly. Because AD and I is a continuous longitudinal study, the researchers could look backward in time.

SPEAKER_01 5:06

Ah, I see.

SPEAKER_00 5:07

They pulled the presupplementation trajectories of the individuals who eventually became omega-3 users. They scrutinized their cognitive scores and brain scans in the years leading up to taking the supplement.

SPEAKER_01 5:18

Okay, so if reverse causality was at play, those presupplementation trend lines would already be sloping downward.

SPEAKER_00 5:25

But they were completely flat.

SPEAKER_01 5:27

Wow.

SPEAKER_00 5:27

There was zero statistical evidence of preexisting decline. In fact, on certain metrics, the presupplementation cohort was trending slightly better than the non-users.

SPEAKER_01 5:38

Oh, better.

SPEAKER_00 5:39

Yeah, a little bit better. The accelerated cognitive decline did not precede the fish oil. It strictly emerged after the introduction of the supplement.

SPEAKER_01 5:47

Okay, so the chronological sequence clearly places the exposure before the deficit.

SPEAKER_00 5:52

Exactly.

SPEAKER_01 5:52

That pretty much eliminates the reverse causality defense entirely. The decline followed the intervention.

SPEAKER_00 5:58

It did.

SPEAKER_01 5:58

So we have to quantify what this accelerated decline actually looks like. Because I mean, cognitive decline is a pretty broad clinical term.

SPEAKER_00 6:05

Aaron Powell It is. It can mean a lot of things.

SPEAKER_01 6:07

Right. If we are talking about a subtle dip on a spreadsheet, that's one thing. But how was this actually manifesting in these individuals?

SPEAKER_00 6:14

Well, the study utilized three independent, highly validated clinical scales. First, you have the MMSE or mini-metal state examination, which functions as a global screening tool for cognitive impairment.

SPEAKER_01 6:27

So a faster drop on that one is bad.

SPEAKER_00 6:29

Right. Second, the ADS Cog 13, which is a much more granular assessment, evaluating specific domains like episodic memory, language retention, and executive function.

SPEAKER_01 6:39

Where a faster

Beating Healthy User Bias

SPEAKER_01 6:40

increase in score is bad, right?

SPEAKER_00 6:41

Exactly. And third, the CDRSB, the clinical dementia rating sum of boxes, which really heavily weighs how cognitive deficits translate into the loss of daily functioning and independence.

SPEAKER_01 6:52

Aaron Powell So what does this all mean? If an omega-3 user is dropping faster across all three of these metrics over a five-year window, how do we contextualize the severity of that acceleration?

SPEAKER_00 7:04

Aaron Powell It's it's significant. The researchers contextualized it by comparing the extra deficit to the typical annual progression rate of a diagnosed Alzheimer's patient.

SPEAKER_01 7:12

Okay, let's hear the numbers.

SPEAKER_00 7:13

The accelerated decline linked to the omega-3 use equated to roughly 7.8% of the typical annual Alzheimer's progression on the MMSE. Wow. On the CDRSB, the metric tracking daily functioning, it accounted for 10.7%. And on the ADS Cog 13, which tracks memory and language, the omega-3 acceleration accounted for a staggering 15.0% of the typical annual progression.

SPEAKER_01 7:38

15%.

SPEAKER_00 7:46

Yeah. It's not just normal aging we're talking about here. It's a measurable, statistically significant shift in their cognitive trajectory.

SPEAKER_01 7:54

If a patient is accumulating that kind of deficit over five years, their brain scans must look just devastating.

SPEAKER_00 8:01

You would think so.

SPEAKER_01 8:02

Right. If cognitive decline is accelerating at that pace, I would expect the researchers to see a massive proliferation of amyloid beta plaques or like a sudden spike in hyperphosphorylated tau tangles.

SPEAKER_00 8:14

That is the logical assumption, absolutely. Because amyloid and tau are the core structural hallmarks of Alzheimer's disease.

SPEAKER_01 8:19

Right.

SPEAKER_00 8:20

But when they look at the PE scans and MRIs, they revealed zero association between omega-3 use and the accumulation of amyloid plaques.

SPEAKER_01 8:27

Zero.

SPEAKER_00 8:27

Zero. There's no associated increase in tau tangles either. And there's no acceleration in gray matter volume atrophy.

SPEAKER_01 8:33

So no brain shrinkage.

SPEAKER_00 8:34

None. The physical structural degradation of the brain was completely unaffected by the supplement.

SPEAKER_01 8:40

Okay, here's where it gets really interesting.

SPEAKER_00 8:42

Yeah, this is the twist.

SPEAKER_01 8:43

If the omega-3s are driving a 15% acceleration in cognitive decline on the ADS COG-13, but they aren't causing plaques, tangles, or brain shrinkage,

Testing Reverse Causality With Timelines

SPEAKER_01 8:55

what is actually causing the memory loss?

SPEAKER_00 8:58

Right, what's driving the decline?

SPEAKER_01 8:59

Aaron Powell If we look at the brain like a house, it's like the structural integrity is totally fine. The drywall is intact, there's no toxic mold in the walls, but somehow the lights are flickering.

SPEAKER_00 9:09

That is a brilliant analogy. The house is structurally identical to the non-users, but the power grid is failing.

SPEAKER_01 9:15

A browno.

SPEAKER_00 9:16

Exactly, an electrical brownout. To find the source of that electrical failure, the researchers shifted away from structural scans and utilized FDG PET imaging.

SPEAKER_01 9:25

Aaron Powell Okay, and what does FDG PET measure?

SPEAKER_00 9:28

It doesn't look at proteins or tissue volume. It measures regional glucose metabolism.

SPEAKER_01 9:32

Ah, energy.

SPEAKER_00 9:33

Right. The human brain is an incredibly energy-demanding organ. It runs almost exclusively on glucose. So when synapses are actively firing, retrieving memories, and processing language, they consume massive amounts of energy.

SPEAKER_01 9:47

So an FDG PET scan allows us to basically watch the brain's metabolic engine running in real time.

SPEAKER_00 9:53

Exactly. And the FDG PET scans of the omega-3 cohort revealed significant longitudinal hypometabolism.

SPEAKER_01 10:00

Hypometabolism, meaning reduced glucose metabolism.

SPEAKER_00 10:04

Yes. These synapses in highly vulnerable Alzheimer's regions were steadily losing their ability to metabolize glucose. It is a profound cellular energy crisis.

SPEAKER_01 10:13

So the synapses aren't being crushed by plaque, they're starving.

SPEAKER_00 10:15

Aaron Ross Powell They're starving. And the researchers used mediation analysis to prove the direct causality here.

SPEAKER_01 10:20

What did they find?

SPEAKER_00 10:22

They calculated that this specific synaptic hypometabolism accounted for 30.8% of the total accelerated decline on the MMSE. Wow. And a massive 40.8% of the decline on the ADS Cog 13.

SPEAKER_01 10:34

Wait, 40%, 40% of that severe memory and language deficit is directly traced back to this synaptic energy failure. Man. This brings us to the ultimate biological contradiction, I think.

SPEAKER_00 10:45

It really is a paradox.

SPEAKER_01 10:47

Because omega-3 polyunsaturated fatty acids, specifically DHA, they are naturally abundant in the brain. They are evolutionary staples of human neurobiology.

SPEAKER_00 10:58

Absolutely.

SPEAKER_01 10:58

Why would introducing a natural structural fat suddenly trigger an energy crisis and shut down glucose metabolism in the synapses?

SPEAKER_00 11:07

Aaron Powell Well the answer lies in the fragile biochemistry of the fat itself.

SPEAKER_01 11:10

Okay.

SPEAKER_00 11:11

DHA is a long-chain polyunsaturated fatty acid, and it contains six distinct chemical double bonds.

SPEAKER_01 11:18

Six double bonds.

SPEAKER_00 11:19

Right. Now, that specific molecular architecture makes the fat incredibly fluid and flexible, which is vital for cellular membrane dynamics.

SPEAKER_01 11:27

Right. That's the whole fluidity thing we always hear about.

SPEAKER_00 11:29

Exactly. However, those multiple double bonds also make DHA incredibly unstable. It is highly susceptible to a destructive chemical process called lipid peroxidation.

SPEAKER_01 11:41

Let me ground this in a real world scenario. If I buy a bottle of highly unsaturated flaxseed oil or commercial fish oil and just leave it on a warm, sunny kitchen counter, it doesn't just sit there.

SPEAKER_00 11:52

No, it definitely doesn't.

SPEAKER_01 11:53

It aggressively oxidizes, it goes rancid, and you can instantly smell the chemical degradation.

SPEAKER_00 11:59

It smells awful,

How Big Is The Decline

SPEAKER_00 12:00

yeah.

SPEAKER_01 12:00

So are we essentially dropping highly Exactly?

SPEAKER_00 12:03

So when oxidized lipids compromise the mitochondrial membrane, they disrupt its structural integrity.

SPEAKER_01 12:09

Oh no. Yeah.

SPEAKER_00 12:10

The membrane can no longer hold the necessary proton gradient for oxidative phosphylation. The cellular machinery stalls. ATP production plummets.

SPEAKER_01 12:19

So this is the exact mechanism driving the hypometabolism we see on the FDG PET scans.

SPEAKER_00 12:25

Exactly. It's not a structural collapse, it's an energy crisis.

SPEAKER_01 12:28

The synapses literally don't have the chemical electricity to function.

SPEAKER_00 12:31

Yes. And furthermore, when the mitochondrial electron transport chain stalls, it begins leaking reactive oxygen species, or ROS.

SPEAKER_01 12:40

More free radicals.

SPEAKER_00 12:42

Right. These are highly destructive free radicals. The leaked ROS then attack the surrounding unoxidized omega-3s in the tissue, creating even more lipid peroxides.

SPEAKER_01 12:51

Which damage more mitochondria.

SPEAKER_00 12:53

Exactly. It initiates a self-reinforcing vicious cycle of oxidative stress and escalating synaptic failure.

SPEAKER_01 12:59

So the structural flexibility that makes DHA so vital also makes it a massive liability.

SPEAKER_00 13:04

It's a double-edged sword.

SPEAKER_01 13:06

It's essentially cellular shrapnel once it oxidizes. This really highlights a terrifying variable, which is the actual quality of the supplements people are swallowing every day.

SPEAKER_00 13:16

Oh, absolutely.

SPEAKER_01 13:17

Because the Liao study specifically notes that the primary intervention for the ADI cohort was commercially available over-the-counter fish oil.

SPEAKER_00 13:25

Right. And independent analyses of commercial fish oil supplements consistently reveal alarming rates of pre-existing oxidation.

SPEAKER_01 13:33

Like they're already bad in the bottle.

SPEAKER_00 13:35

Exactly. A significant percentage of off-the-shelf products are already rancid, heavily oxidized, and chemically compromised before the consumer even breaks the seal.

SPEAKER_01 13:45

That is terrifying. But I want to push back on something here, though.

SPEAKER_00 13:48

Sure. Go ahead.

SPEAKER_01 13:49

If commercial omega-3s are this dangerous, why didn't the randomized clinical trials over the last decade show this accelerated harm? You mentioned earlier that the RCTs were mostly just neutral, not actively destructive.

SPEAKER_00 14:02

Right. It's a very important distinction. There are two critical divergences between those RCTs and this observational data.

SPEAKER_01 14:07

Okay, what's the first?

SPEAKER_00 14:08

First, clinical trials often utilized tightly regulated, highly purified, prescription grade EPA and DHA formulations.

SPEAKER_01 14:17

Ah, so they aren't off the shelf.

SPEAKER_00 14:18

No. They are strictly protected from light and heat to prevent oxidation. They are testing the theoretical ideal of the molecule.

SPEAKER_01 14:26

So the RCTs test the pristine concept while ADI tracks the rancid reality.

SPEAKER_00 14:32

Aaron Powell That's a great way to put it, yes. And the second divergence is time. Time. Yeah. Running a massive randomized clinical trial is prohibitively expensive. So most Alzheimer's RCTs cap their intervention window at 12 to 18 months.

SPEAKER_01 14:46

Oh, right. And 18 months isn't that long.

SPEAKER_00 14:48

Exactly. Neurodegeneration is a notoriously slow, insidious process. The vicious cycle of mitochondrial lipid peroxidation takes years to compound into a measurable cognitive deficit.

SPEAKER_01 14:58

So AD and I's five-year follow-up window basically finally allowed researchers to observe the delayed cumulative damage that an 18-month trial completely misses.

SPEAKER_00 15:07

Aaron Powell Precisely. It takes time for that oxidative damage to really show up on these cognitive scales.

SPEAKER_01 15:11

Wow. This completely fractures the whole more's better approach to neuronutrition.

SPEAKER_00 15:15

It really does.

SPEAKER_01 15:16

But you know, before the listener runs to the kitchen and throws away all their supplements, we should frame this. Because as rigorous as the ADI dataset is, it is still observational.

SPEAKER_00 15:26

Aaron Powell Yes. That's an important limitation to highlight.

SPEAKER_01 15:28

Even with propensity score matching, creating those statistical twins, the researchers can't control for exact daily dosages over a five-year span, nor can they perfectly account for every dietary variable.

SPEAKER_00 15:40

Aaron Powell Right. They don't know if someone took one pill or five pills a day.

SPEAKER_01 15:43

Aaron Powell Exactly. And the cohort is also predominantly white and highly educated, which, you know, limits how universally we can apply these exact percentage drops.

SPEAKER_00 15:52

Aaron Powell That's very true. And this raises an important question regarding what the literature calls the dose-dependent paradox.

SPEAKER_01 15:59

Okay, what does that mean?

No Plaques Or Tangles So Why

SPEAKER_00 16:00

Aaron Ross Powell Well, we shouldn't walk away thinking all omega-3 is neurotoxic. Right. Systematic reviews suggest a highly nuanced U-shaped curve regarding efficacy.

SPEAKER_01 16:09

A U-shaped curve.

SPEAKER_00 16:10

Yeah. Low-dose dietary omega-3s, like those consumed through whole foods, where the fats are protected by natural antioxidants, those are vital for resolving acute inflammation.

SPEAKER_01 16:21

So eating a piece of salmon is still good for you.

SPEAKER_00 16:24

Absolutely. The human body is equipped to manage and utilize small, stable amounts.

SPEAKER_01 16:29

But the moment we isolate those fragile fats, concentrate them into massive gelatin capsules, and flood the system with high doses.

SPEAKER_00 16:38

We overwhelm the brain's antioxidant defense network. The therapeutic benefit literally flips into toxicity. High dose supplementation seems to aggressively reverse any protective effect, actively fueling the oxidative fire.

SPEAKER_01 16:54

Wow.

SPEAKER_00 16:54

And this is especially true for older individuals who already maintain sufficient baseline omega-3 levels through their diet or those harboring high levels of pre-existing cerebral inflammation.

SPEAKER_01 17:04

Right. Their brains are already inflamed.

SPEAKER_00 17:07

Exactly. Dropping highly oxidizable, unstable fats into an already inflamed aging brain is akin to throwing gasoline onto smoldering embers.

SPEAKER_01 17:15

So if I'm standing in the pharmacy aisle right now, looking at a massive wall of golden fish oil capsules, how do I apply this knowledge?

SPEAKER_00 17:22

I think the takeaway here is a radical shift in how we approach preventative health. The era of viewing omega-3s as a uniformly beneficial magic pill for cognitive protection is over. It's a delicate balance.

SPEAKER_01 17:36

It's not a multivitamin.

SPEAKER_00 17:37

No, it's a highly volatile molecule. It requires biological balance modulated by dosage, supplement quality, meaning the oxidation risk, and the individual's baseline brain health.

SPEAKER_01 17:48

So critical thinking is key here. If you are an older adult, introducing high-dose commercial fish oil into your routine is a decision that requires serious clinical oversight.

SPEAKER_00 17:59

Absolutely. You need to be evaluating your specific baseline oxidative state and cognitive health with your doctor.

SPEAKER_01 18:05

Right. So we started this deep dive looking at a paradox. The ultimate brain food seemingly accelerating cognitive decline.

SPEAKER_00 18:13

And the date is really compelling.

SPEAKER_01 18:14

It is. We saw that the deterioration wasn't just some illusion of reverse causality. The exposure clearly preceded the deficit.

SPEAKER_00 18:21

Exactly.

SPEAKER_01 18:22

And we looked past the traditional structural hallmarks of Alzheimer's, you know, the plaques and the tangles, and found a profound energy crisis in the synapses.

SPEAKER_00 18:30

Aaron Ross Powell A measurable failure of glucose metabolism.

SPEAKER_01 18:33

Right. And ultimately we trace that electrical brownout back to the highly unstable chemistry of the very fats we thought were protecting us.

SPEAKER_00 18:41

They act as Trojan horses.

SPEAKER_01 18:43

Exactly. They disrupt mitochondrial

FDG PET Reveals A Brain Energy Crash

SPEAKER_01 18:45

function and trigger a self-reinforcing cascade of oxidative damage. It completely rewrites our understanding of cellular risk.

SPEAKER_00 18:52

Aaron Powell It really challenges everything we thought we knew.

SPEAKER_01 18:55

It does. Which leaves you with a final, somewhat unsettling thought to mull over.

SPEAKER_00 18:59

Oh.

SPEAKER_01 18:59

If the delicate energy grid of the human brain, the synapses responsible for our memories, our language, and our identities, is this incredibly sensitive to the oxidative state of the supposedly healthy, polyunsaturated fats we intentionally supplement.

SPEAKER_00 19:14

Oh, I see where you're going with this.

SPEAKER_01 19:16

How might the massive quantities of highly processed, easily oxidized industrial seed oils saturating our modern daily diets be silently eroding our cellular energy and long term cognitive health?

SPEAKER_00 19:27

That is a terrifying question.

SPEAKER_01 19:29

Right. If the premium supplements are actually damaging the engine, what is the cheap stuff doing? Wow. Thank you for joining us on this deep dive. Stay curious.